Article info
Clinical and epidemiological research
Concise report
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type
- Correspondence to Dr John H Stone, Rheumatology Unit, Yawkey 2C, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; jhstone{at}mgh.harvard.edu
Citation
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type
Publication history
- Received June 15, 2015
- Revised September 14, 2015
- Accepted November 7, 2015
- First published November 30, 2015.
Online issue publication
April 05, 2023
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/